Spectrumedics

Singapore, Singapore Founded: 2018 • Age: 8 yrs
Manufacturer of a therapeutic device for the treatment of arterial vascular calcification
Request Access

About Spectrumedics

Spectrumedics is a company based in Singapore (Singapore) founded in 2018 by Peng Huiqun, Al Ray Tabiliran, and Elynn Phang.. Spectrumedics has raised $14.99 million across 1 funding round from investors including Legend Capital, BC Capital and Yangyun Capital. Spectrumedics offers products and services including Targeted Treatment Device. Spectrumedics operates in a competitive market with competitors including Orchestra BioMed, Biotronik, Inquis Medical, Synaptic Medical and Shenzhen Hannuo Medical Technology, among others.

  • Headquarter Singapore, Singapore
  • Founders Peng Huiqun, Al Ray Tabiliran, Elynn Phang
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Spectrumedics International Pte. Ltd.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $152.11 K (USD)
    183
    as on Dec 31, 2023
  • Net Profit
    $-576.04 K (USD)
    19
    as on Dec 31, 2023
  • EBITDA
    $-576.04 K (USD)
    19
    as on Dec 31, 2023
  • Total Equity Funding
    $14.99 M (USD)

    in 1 rounds

  • Latest Funding Round
    $14.99 M (USD), Series A

    May 07, 2022

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Spectrumedics

Spectrumedics offers a comprehensive portfolio of products and services, including Targeted Treatment Device. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Device for seamless and precise medical treatments

Funding Insights of Spectrumedics

Spectrumedics has successfully raised a total of $14.99M through 1 strategic funding round. The most recent funding activity was a Series A round of $14.99 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $15.0M
  • First Round

    (07 May 2022)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2022 Amount Series A - Spectrumedics Valuation Legend Capital
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Spectrumedics

Spectrumedics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Legend Capital, BC Capital and Yangyun Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture Capital firm focused on multiple sectors
Founded Year Domain Location
-
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Spectrumedics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Spectrumedics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Spectrumedics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Spectrumedics

Spectrumedics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orchestra BioMed, Biotronik, Inquis Medical, Synaptic Medical and Shenzhen Hannuo Medical Technology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Medical devices for hypertension and atherosclerosis treatment are developed.
domain founded_year HQ Location
Cardiovascular products and equipment are developed, manufactured, and distributed.
domain founded_year HQ Location
Developer of medical device for the treatment of peripheral thrombectomy
domain founded_year HQ Location
Medical devices for cardiac arrhythmias and cardiovascular diseases are developed.
domain founded_year HQ Location
Extracorporeal circulation products including ECMO are developed for medical support.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Spectrumedics

Frequently Asked Questions about Spectrumedics

When was Spectrumedics founded?

Spectrumedics was founded in 2018 and raised its 1st funding round 4 years after it was founded.

Where is Spectrumedics located?

Spectrumedics is headquartered in Singapore, Singapore.

Who is the current CEO of Spectrumedics?

Elynn Phang is the current CEO of Spectrumedics. They have also founded this company.

Is Spectrumedics a funded company?

Spectrumedics is a funded company, having raised a total of $14.99M across 1 funding round to date. The company's 1st funding round was a Series A of $14.99M, raised on May 07, 2022.

What is the annual revenue of Spectrumedics?

Annual revenue of Spectrumedics is $152.11K as on Dec 31, 2023.

What does Spectrumedics do?

Manufacturer of a therapeutic device for the treatment of arterial vascular calcification. The company has developed a product named Sonico- an intravascular shock wave balloon catheter system for treating arterial vascular calcification using shock wave therapy.

Who are the top competitors of Spectrumedics?

Spectrumedics's top competitors include Orchestra BioMed, Biotronik and Inquis Medical.

What products or services does Spectrumedics offer?

Spectrumedics offers Targeted Treatment Device.

Who are Spectrumedics's investors?

Spectrumedics has 4 investors. Key investors include Legend Capital, BC Capital, Yangyun Capital, and Wilder Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available